Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan-Reference-Cited by-同舟云学术

Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan

Published:2007-04-20 Issue:1 Volume:26 Page:69-77
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

MIWA H.,SASAKI M.,FURUTA T.,KOIKE T.,HABU Y.,ITO M.,FUJIWARA Y.,WADA T.,NAGAHARA A.,HONGO M.,CHIBA T.,KINOSHITA Y.,

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2007.03350.x/fullpdf

Reference22 articles.

1. An evidence-based appraisal of reflux disease management - The Genval Workshop Report;Dent;Gut,1999

2. Updated guidelines for the diagnosis and treatment of gastroephageal reflux disease;DeVault;Am J Gastroenterol,2005

3. Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease;Fass;Am J Gastroenterol,2003

4. Review article: quality of life issues in gastro-oesophageal reflux diseases;Quigley;Aliment Pharmacol Ther,2005

5. Natural course of gastroesophageal reflux disease: 17-22 year follow-Up of 60 patients;Isolauri;Am J Gastroenterol,1997

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of rabeprazole for the treatment of gastroesophageal reflux disease in a 7-day non-interventional trial;Terapevticheskii arkhiv;2024-09-14

2. Different dosages of vonoprazan for gastroesophageal reflux disease: study protocol for a pragmatic, crossover-cluster, randomized controlled trial with patient preference arms;Trials;2023-12-01

3. Exploring Differences in Pharmacometrics of Rabeprazole between Genders via Population Pharmacokinetic–Pharmacodynamic Modeling;Biomedicines;2023-11-10

4. Chinese consensus on multidisciplinary diagnosis and treatment of gastroesophageal reflux disease 2022;Gastroenterology & Endoscopy;2023-04

5. Efficacy of rabeprazole (Razo®) in the treatment of various clinical variants of GERD: results from the GERBERA study;Meditsinskiy sovet = Medical Council;2022-05-13